A Safety Study of LY3372689 Given By Mouth to Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 5, 2019

Primary Completion Date

June 23, 2019

Study Completion Date

June 24, 2019

Conditions

Healthy

Interventions

DRUG

LY3372689

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

Covance, Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT03819270 - A Safety Study of LY3372689 Given By Mouth to Healthy Participants | Biotech Hunter | Biotech Hunter